Presidido pelos médicos Renato Delascio Lopes e Richard C. Becker, ambos da Duke University, o simpósio terá ainda a participação de três pesquisadores americanos (Christopher B. Granger, David Garcia e Elaine Hylek) e de professores brasileiros. Mais informações no telefone (11) 3849-0379. Confira abaixo a programação do simpósio:
| • Importance of thrombosis and anticoagulation in clinical practice • Endothelium - What is the role in thrombosis • Pathways of Coagulation • Pharmacokinetics and pharmocodynamics of Heparin • Pharmacokinetics and pharmocodynamics of Vitamin K antagonists • Anticoagulation in Acute Coronary Syndrome with ST-segment elevation • Anticoagulation in Acute Coronary Syndrome without ST-segment elevation • Atrial Fibrillation and Acute Coronary Syndrome • Stroke prevention in patients with Atrial Fibrillation • Atrial Fibrillation: What we learned from the trials? • Improve and Endorse – Epidemiology study • Brazilian Guidelines for venous thromboembolism prophylaxis in medical patients • From theory to practice – Safety Zone program • Optimal Duration of therapy for VTE • Prevail and Exclaim Study • Bridging (Perioperative) Anticoagulation – Risks and Benefits • Valve Disease: when and how to do the anticoagulation? • Predicting bleeding risk for patients contemplating warfarin - Where do we stand now? • New Anticoagulants in development • Orthopedics Surgery – How to prevent thromboembolic events? • When and how to do the anticoagulation in patients with Cancer • Hormone therapy versus Thrombosis – Where do we stand in 2008? • How to diagnose and treat heparin induced thrombocytopenia? • Future Directions: Pharmacogenomics |